Stability studies of As4S4 nanosuspension prepared by wet milling in Poloxamer 407

International Journal of Pharmaceutics

Volumn 478, Issue 1, 2015, Pages 187-192

  Bujňáková, Zdenka ^a   Dutková, Erika ^a   Baláž, Matej ^a   Turianicová, Erika ^a   Baláž, Peter ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Arsenic sulfide; Nanomilling; Nanosuspension; Particle size; Stability

Indexed keywords

ARSENIC DERIVATIVE; ARSENIC SULFIDE; NANOMATERIAL; POLOXAMER; UNCLASSIFIED DRUG; ORGANOARSENIC DERIVATIVE; SULFIDE; SUSPENSION;

ARTICLE; CHEMICAL PROCEDURES; CONFORMATIONAL TRANSITION; COVALENT BOND; DARKNESS; DRUG STABILITY; HIGH TEMPERATURE; HYDRODYNAMICS; HYDROPHOBICITY; INFRARED SPECTROSCOPY; IONIC STRENGTH; MICROENVIRONMENT; MOLECULAR WEIGHT; PARTICLE SIZE; PHOTOLUMINESCENCE; PHYSICAL CHEMISTRY; STEREOSPECIFICITY; ULTRAVIOLET IRRADIATION; ULTRAVIOLET SPECTROSCOPY; WET MILLING; ZETA POTENTIAL; CHEMISTRY; DRUG FORMULATION; PROCEDURES; RADIATION RESPONSE; SUSPENSION; TEMPERATURE; ULTRAVIOLET RADIATION;

ARSENICALS; DRUG COMPOUNDING; DRUG STABILITY; NANOSTRUCTURES; PARTICLE SIZE; POLOXAMER; SULFIDES; SUSPENSIONS; TEMPERATURE; ULTRAVIOLET RAYS;

EID: 84911863703     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.11.043     Document Type: Article

References (36)

1. P. Baláž Mechanochemistry in Nanoscience and Mineral Enginering 2008 Springer Verlag Berlin Heidelberg
2. P. Baláž, and J. Sedlák Arsenic in cancer treatment: challenges for application of realgar nanoparticles (a minireview) Toxins (Basel) 2 2010 1568 1581
3. 4 nanoparticles Mater. Lett. 63 2009 1542 1544
4. 4 nanoparticles: physico-chemical properties and anti-cancer effects J. Nano Res. 18-19 2012 149 155
5. R. Boistelle, and J.P. Astier Crystallization mechanisms in solution J. Cryst. Growth 90 1988 14 30
6. S. Chen, C. Guo, G.H. Hu, J. Wang, J.H. Ma, X.F. Liang, L. Zheng, and H.Z. Liu Effect of hydrophobicity inside PEO-POP-PEO block copolymer micelles on the stabilization of gold nanoparticles: experiments Langmuir 22 2006 9704 9711
7. J.X. Deng, L. Huang, and F. Liu Understanding the structure and stability of paclitaxel nanocrystals Int. J. Pharm. 390 2010 242 249
8. J.J. Escobar-Chávez, M. López-Cervantes, A. Naik, Y.N. Kalia, D. Quintanar-Guerro, and A. Ganem-Quintanar Applications of thermoreversible pluronic F-127 gels in pharmaceutical formulations J. Pharm. Pharm. Sci. 9 2006 339 358
9. M. Frumar, Z. Černošek, J. Jedelský, B. Frumarová, and T. Wagner Photoinduced changes of structure and properties of amorphous binary and ternary chalcogenides J. Optoelectron. Adv. Mater. 3 2001 177 188
10. M. Frumar, Z. Polák, M. Černošek, B. Vlček, and B. Frumarová Physics and Applications of Non-crystalline Semiconductors in Optoelectronics 1997 Kluwer Academic Publishers
11. M. Frumar, Z. Polák, Z. Černošek, and B. Frumarová Photoinduced effects in amorphous chalcogenides Chem. Pap. 51 1997 310 327
12. J. Gilbert, J. Hadgraft, A. Bye, and L. Brookes Drug release from pluronic F-127 gels Int. J. Pharm. 32 1986 223 228
13. C. Guo, J. Wang, H.Z. Liu, and J.Y. Chen Hydratation and coformation of temperature dependent micellization of PEO-PPP-PEO block copolymers in aquaeous solution by FT-Raman Langmuir 15 1999 2703 2708
14. C.-J. Kim Surface Chemistry and Colloids, Advanced Pharmaceutics: Physico-Chemical Principles 2004 CRC Press USA
15. 0.6 J. Non-Cryst. Solids 226 1998 85 91
16. M.F. Lengke, and R.N. Tempel Geochemical modeling of arsenic sulfide oxidation kinetics in a mining environment Geochim. Cosmochim. Acta 69 2005 341 356
17. J.T. Li, and K.D. Caldwell Plasma protein interactions with Pluronic treated colloids Colloid Surf. B 7 1996 9 22
18. H.L. Liu, P. Hou, W.X. Zhang, Y.K. Kim, and J.H. Wu The synthesis and characterization of polymer-coated FeAu multifunctional nanoparticles Nanotechnology 21 2010 335602
19. P. Liu, X. Rong, J. Laru, B. van Ven, J. Kiesvaara, J. Hirvonen, T. Laaksonen, and L. Peltonen Nanosuspensions of poorly soluble drugs: preparation and development by wet milling Int. J. Pharm. 411 2011 215 222
20. E. Merisko-Liversidge, and G.G. Liversidge Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology Adv. Drug Deliv. Rev. 63 2011 427 440
21. P.R. Mishra, L.A. Shaal, R.H. Müller, and C.M. Keck Production and characterization of Hesperetin nanosuspensions for dermal delivery Int. J. Pharm. 453 2009 182 189
22. S.M. Moghimi, and A.C. Hunter Poloxamers and poloxamines in nanoparticle engineering and experimental medicine Trends Biotechnol. 18 2000 412 420
23. S.M. Moghimi, I.S. Muir, L. Illum, S.S. Davis, and V. Kolb-Bachfen Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum Biochim. Biophys. Acta 1179 1993 157 165
24. Müller Colloidal carriers for controled drug delivery and targeting Wissenschaftliche Verlagsgesellschaft GmbH 1991 CRC Press Stuttgart, Boston
25. S.N. Pace, G.W. Pace, I. Parikh, and A.K. Mishra Novel injectable formulations of insoluble drugs Pharm. Technol. 23 1999 116 134
26. 3) induced autophagy and apoptosis in human melanoma cells in vitro Neoplasma 61 2014 700 709
27. B.E. Rabinov Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796
28. Q.-H. Shou, C. Guo, H.-S. Gao, H.-C. Zhou, C.-Z. Liu, and H.-Z. Liu Facile synthesis of gold nanoparticles using pluronic block copolymers Chin. J. Process Eng. 11 2011 711 715
29. G. Storm, S.O. Belliot, T. Daemen, and D.D. Lasic Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system Adv. Drug Deliv. Rev. 16 1995 31 48
30. Y. Tian, X. Wang, R. Xi, W. Pan, S. Jiang, Z. Li, Y. Zhao, G. Gao, and D. Liu Enhanced antitumor activity of realgar mediated by milling to nanosize Int. J. Nanomed. 9 2014 745 757
31. Z.Y. Wang Arsenic compounds as anticancer agents Cancer Chemother. Pharmacol. 48 2001 72 76
32. Y. Wang, Y. Zheng, L. Zhang, Q. Wang, and D. Zhang Stability of nanosuspensions in drug delivery J. Control. Release 172 2013 1126 1141
33. J.-Z. Wu, and P.C. Ho Evaluation of the in vitro activity and in vivo bioavailability of realgar nanoparticles prepared by cryo-grinding Eur. J. Pharm. Sci. 29 2006 35 44
34. 4) and its recent development as an anticancer agent J. Ethnopharmacol. 135 2011 595 602
35. H.-Q. Ye, L. Gan, X.-L. Yang, and H.-B. Xu Membrane-associated cytotoxicity induced by realgar in promyelocytic leukemia HL-60 cells J. Ethnopharmacol. 103 2006 366 371
36. L. Yuan, C. Wang, W. Liu, B. Gou, and T. Zhang Realgar induces differentiation through ROS-dependent mitochondrial pathway in HL-60 cells J. Chin. Pharm. Sci. 22 2013 184 189